News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

On the left side of the graphic is a caucasian man wearing glasses and a suit. The photo shows him in portrait mode. The right side is blue and has a white logo and text.
News Release

Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.

Read More
A logo on white background
News Release

INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.

Read More
A human hand holds a magnifying glass up to a computer screen. The screen is out of focus but the area under the magnifying glass is crystal clear. It appears to be the website for the FDA.
News Release

Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
4 Major Drug Shortages That Could Affect You in 2024

4 Major Drug Shortages That Could Affect You in 2024

Best Life, December 19, 2023

In today's world, we expect what we need to be available when we need it. That mindset certainly applies to the different medications we're prescribed, which can be debilitating to go without. But now, the U.S. is facing an onslaught of drug shortages, with over 300 drugs in short supply as of late spring—the highest number in a decade. Making matters worse, the average shortage impacts a least half a million people, according to an Office of the Assistant Secretary for Planning and Evaluation (ASPE) report to Congress. And we could see several drug shortages continue in 2024.

NewHydrogen CEO Steve Hill Discusses Hydrogen’s Role in Future Fuels with Georgia Tech Energy and Environment Expert

NewHydrogen CEO Steve Hill Discusses Hydrogen’s Role in Future Fuels with Georgia Tech Energy and Environment Expert

The Associated Press, December 19, 2023

SANTA CLARITA, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCMKTS:NEWH), the developer of a breakthrough technology that uses clean energy and water to produce the world’s cheapest green hydrogen, today announced that in a recent podcast the Company’s CEO Steve Hill spoke with Dr. Valerie M. Thomas, Georgia Tech Andersen Interface Chair of Natural Systems in the H. Milton Stewart School of Industrial and Systems Engineering and in the School of Public Policy regarding the challenges and opportunities in evaluating the carbon footprint of different fuels. Their discussion provided a comprehensive overview of the current state and future possibilities of hydrogen as a pivotal component in the global transition to sustainable energy.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine